Complete conformational space of the potential HIV-1 reverse transcriptase inhibitors d4U and d4C. A quantum chemical study

Alla G. Ponomareva, Yevgen P. Yurenko, Roman O. Zhurakivsky, Tanja van Mourik and Dmytro M. Hovorun

Phys. Chem. Chem. Phys., 2012, 14, 6787
DOI: 10.1039/c2cp40290d

The diverse pharmacology and medicinal chemistry of phosphoramidates – a review

Fabrício M. Oliveira, Luiz C. A. Barbosa and Fyaz M. D. Ismail

RSC Adv., 2014, 4, 18998
DOI: 10.1039/C4RA01454E

Chemical and enzymatic stability of amino acid derived phosphoramidates of antiviral nucleoside 5′-monophosphates bearing a biodegradable protecting group

Anna Leisvuori, Yuichiro Aiba, Tuomas Lönnberg, Päivi Poijärvi-Virta, Laurence Blatt, Leo Beigelman and Harri Lönnberg

Org. Biomol. Chem., 2010, 8, 2131
DOI: 10.1039/b924321f

Aryl H-phosphonates. 19. New anti-HIV pronucleotide phosphoramidate diesters containing amino- and hydroxypyridine auxiliaries

Joanna Romanowska, Krystian Kolodziej, Michal Sobkowski, Marta Rachwalak, Tomasz Jakubowski, Justyna Golebiewska, Adam Kraszewski, Jerzy Boryski, Aleksandra Dabrowska and Jacek Stawinski

European Journal of Medicinal Chemistry, 2019, 164, 47
DOI: 10.1016/j.ejmech.2018.12.038

Mechanism for dissociative hydrolysis of pyrimidine nucleoside d4N: Inversion vs retention

Yi Zeng, Yuexin Zhao, Wei Zhang and Yang Jiang

Chemical Physics, 2023, 568, 111845
DOI: 10.1016/j.chemphys.2023.111845

PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage

Olivia A. Lambourne, Shane Bell, Léa P. Wilhelm, Erika B. Yarbrough, Gabriel G. Holly, Oliver M. Russell, Arwa M. Alghamdi, Azeza M. Fdel, Carmine Varricchio, Emma L. Lane, Ian G. Ganley, Arwyn T. Jones, Matthew S. Goldberg and Youcef Mehellou

J. Med. Chem., 2023, 66, 7645
DOI: 10.1021/acs.jmedchem.3c00555

Synthesis, molecular properties and DFT studies of new phosphoramidates as potential urease inhibitors

Fabricio M. Oliveira, Luiz C. A. Barbosa, Antônio J. Demuner, Célia R. A. Maltha, Silvana R. Pereira, Lívia P. Horta and Luzia V. Modolo

Med Chem Res, 2014, 23, 5174
DOI: 10.1007/s00044-014-1113-y

Aryl H-Phosphonates 18. Synthesis, properties, and biological activity of 2′,3′-dideoxynucleoside (N-heteroaryl)phosphoramidates of increased lipophilicity

Krystian Kolodziej, Joanna Romanowska, Jacek Stawinski, Jerzy Boryski, Aleksandra Dabrowska, Andrzej Lipniacki, Andrzej Piasek, Adam Kraszewski and Michal Sobkowski

European Journal of Medicinal Chemistry, 2015, 100, 77
DOI: 10.1016/j.ejmech.2015.06.004

Nucleoside Mono‐ and Diphosphate Prodrugs of 2′,3′‐Dideoxyuridine and 2′,3′‐Dideoxy‐2′,3′‐didehydrouridine

Florian Pertenbreiter, Jan Balzarini and Chris Meier

ChemMedChem, 2015, 10, 94
DOI: 10.1002/cmdc.201402295

Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs

Ugo Pradere, Ethel C. Garnier-Amblard, Steven J. Coats, Franck Amblard and Raymond F. Schinazi

Chem. Rev., 2014, 114, 9154
DOI: 10.1021/cr5002035

The Design, Synthesis and Antiviral Evaluation of a Series of 5-trimethylsilyl-1-β-d-(arabinofuranosyl) uracil phosphoramidate ProTides

Youcef Mehellou, Jan Balzarini and Christopher McGuigan

Antivir Chem Chemother, 2010, 20, 153
DOI: 10.3851/IMP1476

Synthesis of Phosphoramidate Prodrugs: ProTide Approach

Michaela Serpi, Karolina Madela, Fabrizio Pertusati and Magdalena Slusarczyk

CP Nucleic Acid Chemistry, 2013, 53
DOI: 10.1002/0471142700.nc1505s53

Design and synthesis of novel distamycin-modified nucleoside analogues as HIV-1 reverse transcriptase inhibitors

Chao Li, Chunying Ma, Jin Zhang, Ning Qian, Jingjing Ding, Renzhong Qiao and Yufen Zhao

Antiviral Research, 2014, 102, 54
DOI: 10.1016/j.antiviral.2013.12.002

Aryloxy Diester Phosphonamidate Prodrugs of Phosphoantigens (ProPAgens) as Potent Activators of Vγ9/Vδ2 T-Cell Immune Responses

Hachemi Kadri, Taher E. Taher, Qin Xu, Maria Sharif, Elizabeth Ashby, Richard T. Bryan, Benjamin E. Willcox and Youcef Mehellou

J. Med. Chem., 2020, 63, 11258
DOI: 10.1021/acs.jmedchem.0c01232

Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism

Youcef Mehellou, Rocco Valente, Huw Mottram, Elisabeth Walsby, Kenneth I. Mills, Jan Balzarini and Christopher McGuigan

Bioorganic & Medicinal Chemistry, 2010, 18, 2439
DOI: 10.1016/j.bmc.2010.02.059

Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells

Youcef Mehellou, Jan Balzarini and Christopher McGuigan

ChemMedChem, 2009, 4, 1779
DOI: 10.1002/cmdc.200900289

Synthesis, Anti‐HIV Activity Studies, and in silico Rationalization of Cyclobutane‐Fused Nucleosides

Antoni Figueras, Rosa Miralles‐Llumà, Ramon Flores, Albert Rustullet, Félix Busqué, Marta Figueredo, Josep Font, Ramon Alibés and Jean‐Didier Maréchal

ChemMedChem, 2012, 7, 1044
DOI: 10.1002/cmdc.201200059

Treatment of Breast and Lung Cancer Cells with a N-7 Benzyl Guanosine Monophosphate Tryptamine Phosphoramidate Pronucleotide (4Ei-1) Results in Chemosensitization to Gemcitabine and Induced eIF4E Proteasomal Degradation

Shui Li, Yan Jia, Blake Jacobson, Joel McCauley, Robert Kratzke, Peter B. Bitterman and Carston R. Wagner

Mol. Pharmaceutics, 2013, 10, 523
DOI: 10.1021/mp300699d

Structure–activity relationships of the antiviral D4T and seven 4′-substituted derivatives using MP2 and DFT methods

M. Alcolea Palafox and N. Iza

Struct Chem, 2013, 24, 967
DOI: 10.1007/s11224-012-0193-x

Spectroscopic and dynamic NMR study, X-ray crystallography and DFT calculations of two phosphoramidates: (C4H3O2)P(O)(Cl)C6H14N and (C4H3O2)P(O)(C6H11NH)2

F.M. Oliveira, L.C.A. Barbosa, A.J. Demuner, C.R.A. Maltha, S.A. Fernandes, J.W.de M. Carneiro, R.S. Corrêa and A.C. Doriguetto

Journal of Molecular Structure, 2013, 1046, 64
DOI: 10.1016/j.molstruc.2013.04.059

Synthesis, biological evaluation and molecular docking studies of Combretastatin A-4 phosphoramidates as novel anticancer prodrugs

Shaowu Zhang, Tang Li, Wan Pang, Jingjing Wu, Fulong Wu, Yangyang Liu and Fanhong Wu

Med Chem Res, 2020, 29, 2192
DOI: 10.1007/s00044-020-02632-2

Evaluation of some density functional methods for the estimation of hydrogen and carbon chemical shifts of phosphoramidates

Fabricio M. Oliveira, Luiz C.A. Barbosa, Sergio A. Fernandes, Mateus R. Lage, José Walkimar de M. Carneiro and Mikhail A. Kabeshov

Computational and Theoretical Chemistry, 2016, 1090, 218
DOI: 10.1016/j.comptc.2016.06.025

Phosphoramidates and phosphonamidates (ProTides) with antiviral activity

Magdalena Slusarczyk, Michaela Serpi and Fabrizio Pertusati

Antivir Chem Chemother, 2018, 26
DOI: 10.1177/2040206618775243

[d4U]-Spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase

Yassir Younis, Roger Hunter, Clare I. Muhanji, Ian Hale, Rajinder Singh, Christopher M. Bailey, Todd J. Sullivan and Karen S. Anderson

Bioorganic & Medicinal Chemistry, 2010, 18, 4661
DOI: 10.1016/j.bmc.2010.05.025

A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria

Yuri F. Rego, Marcelo P. Queiroz, Tiago O. Brito, Priscila G. Carvalho, Vagner T. de Queiroz, Ângelo de Fátima and Fernando Macedo Jr.

Journal of Advanced Research, 2018, 13, 69
DOI: 10.1016/j.jare.2018.05.003

Synthesis and characteristics of sugar-phosphoramidates: A spectroscopic study

Afraz Subratti, Lorale J. Lalgee and Nigel Kevin Jalsa

Tetrahedron Letters, 2018, 59, 3384
DOI: 10.1016/j.tetlet.2018.07.066